Spectranetics, based in Colorado Springs, Colorado, won FDA approval to bring to the U.S. market its Stellarex drug-coated balloon catheter. The device is designed and indicated for helping to restore and keep open the lumen of superficial femoral and popliteal arteries in patients with peripheral artery disease.
The device features the company (Read more...)